Source：The Insides Company Limited
On：16th December 2024
Organisation：The Insides Company Limited, HMS Endo, Saesco Medical Group
The Insides Company, a medical technology company focused on the development and commercialisation of novel chyme reinfusion therapy (CRT) devices for the treatment of intestinal failure, today announced HMS Endo, A Saesco Medical Group company, as the exclusive partner for Poland following the signing of the distribution agreement.
Garth Sutherland, CEO of The Insides Company, commented “we are excited by the opportunity to work with the excellent team at HMS Endo From our first meetings with Jordi and Sylwester we could see a very good fit for both companies and their track record and long experience is ideal. We have already seen interest in Poland so this appointment of our latest partner in Europe is ideal. Commenting on the agreement Jordi Fluvia, CEO of SAESCO Medical “Since its inception, the goal of our company was to learn, select and bring best in class medical technologies to market and the addition of the innovative technology from The Insides Company continues this journey”.
About Type II Intestinal Failure and Chyme Reinfusion Therapy
Type II intestinal failure is the inability of the gut to absorb necessary water, macronutrients, micronutrients, and electrolytes to sufficiently sustain life without intravenous supplementation or replacement. This can be due to malabsorption (small bowel mucosal disease), surgical resection (short bowel syndrome), fistulae, dysmotility, or mechanical obstruction. Under the standard care pathway, patients recovering from colorectal surgery often have an enterostomy created to divert intestinal contents (chyme) away from the surgical site as it heals. The enterostomy is typically left open for 6-12 months, and during this time the chyme that is collected is disposed of, which can result in intestinal failure and other complications. The Insides System is a purpose-built medical device for performing chyme reinfusion therapy. Chyme reinfusion is a practice in the management of patients with high-output enterocutaneous fistulas, and high-output enterostomies.
About HMS Endo,
HMS Endo is a company specializing in the distribution of equipment used in surgery, in particular coloproctology, laparoscopy, obesity treatment and urogynaecology. The company was founded in 2003 and in 2021 joined the Saesco Group. SAESCO Medical was founded in 2009 in Barcelona with the goal of becoming a key player in the growing space of Obesity and Metabolic related Medical Devices.
About The Insides Company
The Insides Company is a provider of life-saving medical devices that are purpose-designed to perform chyme reinfusion therapy for the treatment of patients with severe intestinal failure. The Insides Company’s vision is ‘a world that refeeds’.
Contacts
HMS Sp. z o. o.
Stanisława Augusta 73/16, 03-846 Warsaw
phone：602 325 336
Email：biuro@hmsendo.pl
www.hmsendo.pl
The Insides Company
Mark Harvie, Consultant
Telephone：+44 7970 546778
Email：sales@theinsides.co
www.theinsides.co
.png){kind=small}
